What is it about?
Carotid Artery Stenting (CAS) is being widely performed in patients with symptomatic and asymptomatic carotid stenosis at high risk for carotid endarterectomy. The safety and efficacy of CAS has been well demonstrated in multiple trials and is accepted as an alternative therapy to the surgical approach in multidisciplinary guidelines.
Featured Image
Why is it important?
The safety and efficacy of CAS has been well demonstrated in multiple trials and is accepted as an alternative therapy to the surgical approach in multidisciplinary guidelines.
Perspectives
The CLEAR-ROAD study is a prospective, multinational, single-arm study in high surgical risk patients with severe carotid stenosis. A total of 100 non-consecutive patients (31% symptomatic patients) were enrolled in nine clinical centers divided over Belgium, Germany and Italy. The CAS procedure (e.g. vascular access, the use and type of embolic protection devices) was performed according to the physician’s standard of care and based on the instructions for use of the RoadSaver carotid stent system. An EPD was used in 58% of the cases.
Professor Paulo Eduardo Ocke Reis
Universidade Federal Fluminense
Read the Original
This page is a summary of: The Roadsaver Stent to Treat Carotid Lesions, Journal of Vascular and Endovascular Surgery, January 2017, Scitechnol Biosoft Pvt. Ltd.,
DOI: 10.21767/2573-4482.100047.
You can read the full text:
Contributors
The following have contributed to this page
